Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Clinical pharmacology and therapy

• Publication date

  2001-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1067/mcp.2001.113989PMID 11240971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surrogate endpoints: A basis for a rational approach

  2006cited by this paper
• The contribution of clinical pharmacology surrogates and models to drug development--a critical appraisal.

  2003cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• [Surrogate end points].

  2000cited by this paper
• Bee sting dysphagia.

  1999cited by this paper
• Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein

  1999cited by this paper
• Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.

  1999cited by this paper
• Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.

  1999cited by this paper
• Are surrogate markers adequate to assess cardiovascular disease drugs?

  1999cited by this paper
• Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.

  1998cited by this paper
• Surrogacy in HIV-1 clinical trials.

  1998cited by this paper
• DNA Damage as an Intermediate Biomarker in Intervention Studies

  1997cited by this paper
• Meta-analysis for the evaluation of potential surrogate markers.

  1997cited by this paper
• Estimating the proportion of treatment effect explained by a surrogate marker.

  1997cited by this paper
• Surrogate End Points in Clinical Trials: Are We Being Misled?

  1996cited by this paper
• Importance of surrogate markers in evaluation of antiviral therapy for HIV infection.

  1996cited by this paper
• Efficacy Measures: Surrogates or Clinical Outcomes?

  1996cited by this paper
• Evaluating surrogate markers.

  1995cited by this paper
• New molecular endpoints and methods for routine toxicity testing.

  1995cited by this paper
• Slow recovery of human brain MAO B after L‐Deprenyl (Selegeline) withdrawal

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Surrogate Markers in AIDS: Where Are We? Where Are We Going?

  1992cited by this paper
• Statistical validation of intermediate endpoints for chronic diseases.

  1992cited by this paper
• A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group.

  1991cited by this paper
• Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

  1991cited by this paper
• Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

  1991cited by this paper
• Surrogate endpoints in clinical trials: definition and operational criteria.

  1989cited by this paper
• A survey of the pharmaceutical industry in the British Zone of Germany.

  1947cited by this paper

• Early effects of cigarette smoke on adolescent endothelial functions: a novel endocan/cotinine ratio approach

  2026cites this paper
• What new renal biomarkers tell us about renal physiology: Collection: physiology applied to ICU.

  2026cites this paper
• Tissue-based biomarkers of clinical relevance at the invasive tumor front in oral squamous cell carcinoma: a scoping review protocol.

  2026cites this paper
• Covalent organic polymer-based biosensor for autism spectrum disorder biomarker detection

  2026cites this paper
• Untargeted Metabolomics Profiling of a PFAS-Exposed Flemish Population.

  2026cites this paper
• Biomarkers of Coagulation Disorders-Where to from Here?

  2026cites this paper
• MALDI Mass Spectrometry in Metabolic Diagnostics: Advances in Biofluid and Spatial Metabolic Analysis

  2026cites this paper
• Parental Perceptions of Benefits and Risks Concerning Mental Health Biomarker Testing for Adolescents.

  2026cites this paper
• Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association.

  2026cites this paper
• New biomarker for erectile dysfunction: soluble tumor necrosis factor-like weak inducer of apoptosis.

  2026cites this paper
• Survival and Surrogate Biomarkers in Interventional Oncology Trials: Pitfalls, Challenges, and Future Directions.

  2026cites this paper
• Assessing the impact of manual therapy in the management of nonspecific low back pain: a scoping review of the outcomes used in clinical trials.

  2026cites this paper
• Calprotectin as an immune-dysregulation biomarker in amyotrophic lateral sclerosis: Insights for diagnosis and therapy.

  2026cites this paper
• Glucosylsphingosine (Lyso-Gb1): An Update on Its Use as a Biomarker in Gaucher Disease.

  2026cites this paper
• Biosynthesis of randomly arranged G-quadruplexes for amplified dual-mode detection of alkaline phosphatase activity based on an on-off cyanine probe recognition.

  2026cites this paper
• Proximal Pulmonary Artery Stiffening as a Biomarker of Cardiopulmonary Aging

  2026cites this paper
• The progress of biomarkers detection to lung cancer.

  2026cites this paper
• Plasma brain-derived tau: analytical and clinical validation of the first commercial immunoassay.

  2026cites this paper
• Biomarcadores predictivos del resultado visual en membrana epirretiniana idiopática

  2026cites this paper
• Obesity, Metabolic Syndrome and MASLD in Children: Inflammation as the Missing Link-A Short Narrative Review.

  2026cites this paper
• TPI1 and TPM4 are strong candidate RNA biomarkers for systemic sclerosis

  2026cites this paper
• Unlocking the power of extracellular vesicles: multi-omics integration for cancer biomarker discovery

  2026cites this paper
• The Role of Proinflammatory Biomarkers in Oral Cancer Pathophysiology.

  2026cites this paper
• Emerging trends and smart integration of wireless and artificial intelligence in 2D hybrid materials-based biosensors

  2026cites this paper
• Hereditary Ataxias: From Pathogenesis and Clinical Features to Neuroimaging, Fluid, and Digital Biomarkers—A Scoping Review

  2026cites this paper
• Evaluation of progression-free status at 24 months as a surrogate endpoint for overall survival in patients with human papillomavirus-positive oropharyngeal cancer: a retrospective cohort study.

  2026cites this paper
• The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health.

  2026cites this paper
• Monitoring physiological correlates or biomarkers of welfare in animals – practical applications of vibrational spectroscopy and machine learning

  2026cites this paper
• A Comparative Analysis of Differences in Salivary hBD-2 Levels and Their Correlation with Dental Caries and Unstimulated Saliva pH in Children with Primary and Permanent Dentition.

  2026cites this paper
• Sphingolipids in Emotional Well‐Being

  2026cites this paper
• Assessment of drug levels as a biomarker in rheumatoid arthritis

  2026cites this paper
• Reflections on Reductionist Clinical Psychological and Neuroscience Education: Putting the "Me" Back in Mental Disorders.

  2026cites this paper
• Effect of strength training with blood flow restriction on body composition, lipid profile and serum irisin levels in elderly women

  2026cites this paper
• SPIRA-BM: Biomarkers for Respiratory Conditions by Audio Analysis via Artificial Intelligence

  2025cites this paper
• Circulating MicroRNAs Are Promising Biomarkers for Assessing the Risk of Antipsychotic-Induced Metabolic Syndrome (Review): Part 1

  2025cites this paper
• Clinical and Biofluid Biomarkers of Sleep Dysfunction in Parkinson's Disease.

  2025cites this paper
• Lung cancer risk assessment by prediction model: a global perspective

  2025cites this paper
• [Building precision psychiatry: why and how?]

  2025cites this paper
• Implications of Oxidative Stress in the Pathophysiological Pathways of Heart Failure

  2025cites this paper
• Biomarkers in inflammatory neuropathies: where are we?

  2025cites this paper
• Fluid biomarkers in atypical Parkinsonism: current state and future perspectives

  2025cites this paper
• Retinal macular morphology and cognitive functions in unmedicated first-episode psychosis patients.

  2025cites this paper
• Innovations in wearable biosensors: A pathway to 24/7 personalized healthcare

  2025cites this paper
• Interpreting Lipid Biomarkers in Cardiac Allograft Vasculopathy.

  2025cites this paper
• Extracellular Vesicles Derived from Trypanosomatids: The Key to Decoding Host–Parasite Communication

  2025cites this paper
• Protocol Development for Investigator‐Sponsored Clinical Studies

  2025cites this paper
• Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial

  2025cites this paper
• Emerging technologies for monitoring breast cancer response to neoadjuvant chemotherapy: a systematic scoping review

  2025cites this paper
• Exploring the types of airway inflammation in hospitalized children with asthma

  2025cites this paper
• Prognostic Value of Urinary Biomarkers in Proteinuria Progression in IgA Nephropathy Patients Treated with Budesonide

  2025cites this paper
• Biomarkers in autoimmune myasthenia gravis: A narrative review

  2025cites this paper
• From Circulating Biomarkers to Polymorphic Variants: A Narrative Review of Challenges in Thrombophilia Evaluation

  2025cites this paper
• Correlation of serum biomarkers with clinicoradiological assessments in patients with moderate and severe traumatic brain injury.

  2025cites this paper
• Visual analytics framework for survival analysis and biomarker discovery

  2025cites this paper
• Surrogate endpoints in diabetic kidney disease: current perspectives and future directions

  2025cites this paper
• The Role of Non-Coding RNAs in ALS

  2025cites this paper
• Performance of Blood-Based Biomarkers for Human Circadian Pacemaker Phase: Training Sets Matter As Much As Feature-Selection Methods

  2025cites this paper
• Retinal vessel density using optical coherence tomography angiography as a potential biomarker in patients with cerebral small vessel disease

  2025cites this paper
• Does serial procalcitonin monitoring predict clinical outcomes in children with sepsis? A diagnostic stewardship study

  2025cites this paper
• Early biomarker for autism spectrum disorder unveiled – what are we learning?

  2025cites this paper
• The importance of ALPK1 kinase functionality as a potential biomarker for inflammatory diseases

  2025cites this paper
• Increase of Plasma Biomarkers in Friedreich's Ataxia: Potential Insights into Disease Pathology

  2025cites this paper
• ВЛИЯНИЕ ФИЗИЧЕСКОЙ АКТИВНОСТИ НА БИОМАРКЕРЫ СТАРЕНИЯ В НОРМЕ И ПРИ ПАТОЛОГИИ (аналитический обзор)

  2025cites this paper
• The screening assessment of pro-inflammatory, anti-inflammatory, Th1, Th2 and Th17 cytokines in saliva of patients with ischemic stroke

  2025cites this paper
• Leveraging mHealth wearables for managing patients with Alzheimer's disease: a scoping review.

  2025cites this paper
• Targeted and Non-Targeted Metabolomic Evaluation of Cerebrospinal Fluid in Early Phase Schizophrenia: A Pilot Study from the Hopkins First Episode Psychosis Project

  2025cites this paper
• Short-Term and Long-Term Effects of Inhaled Ultrafine Particles on Blood Markers of Cardiovascular Diseases: A Systematic Review and Meta-Analysis

  2025cites this paper
• Analysis of Voice, Speech, and Language Biomarkers of Parkinson’s Disease Collected in a Mixed Reality Setting

  2025cites this paper
• Biomarkers in Parkinson's Disease.

  2025cites this paper
• Unveiling the revolutionary approach for psoriasis management: Leveraging the breakthrough capabilities of hyaluronic acid.

  2025cites this paper
• An iterative ROC procedure identifies white matter tracts diagnostic for traumatic brain injury: an exploratory analysis in U.S. Veterans

  2025cites this paper
• Evaluation of S100B, NSE, MBP and GFAP serum levels in children with attention deficit hyperactivity disorder

  2025cites this paper
• Salivary periostin levels as a non-invasive biomarker and their clinical correlates among healthy and periodontitis patients—a cross-sectional analytical study

  2025cites this paper
• Vocal biomarkers correlate with FEV1 variations during methacholine challenge

  2025cites this paper
• Plasma proteomics in pediatric patients with sepsis– hopes and challenges

  2025cites this paper
• Decoy receptor 3 as a prognostic biomarker for sepsis and septic shock according to the Sepsis-3 definitions

  2025cites this paper
• Targeting and engineering biomarkers for prostate cancer therapy.

  2025cites this paper
• Era of surrogate endpoints and accelerated approvals: a comprehensive review on applicability, uncertainties, and challenges from regulatory, payer, and patient perspectives

  2025cites this paper
• Biomarkers in Peri‐Implant Crevicular Fluid of Healthy Implants and Those With Peri‐Implant Diseases: A Systematic Review and Meta‐Analysis

  2025cites this paper
• MicroRNAs as Epigenetic Biomarkers of Pathogenetic Mechanisms of the Metabolic Syndrome Induced by Antiseizure Medications: Systematic Review

  2025cites this paper
• Electroencephalographic Biomarkers for Neuropsychiatric Diseases: The State of the Art

  2025cites this paper
• The Role of Biomarkers in Acute Pain: A Narrative Review

  2025cites this paper
• Fecal and Serum Calprotectin Concentrations in Cats With Chronic Enteropathies Before and During Treatment

  2025cites this paper
• Metrology for MRI: the field you’ve never heard of

  2025cites this paper
• Multiplex Detection of Biomarkers Empowered by Nanomaterials

  2025cites this paper
• [Animal experimental models in the study of age-dependent cerebral microangiopathy].

  2025cites this paper
• Advances in biomarkers in multiple system atrophy

  2025cites this paper
• Biomarkers of endometriosis.

  2025cites this paper
• Recent advance in single-molecule detection and imaging

  2025cites this paper
• Application of non‑coding RNAs in tumors (Review)

  2025cites this paper
• Improving polygenic risk prediction of renal function by removing biomarker-specific effects

  2025cites this paper
• Blood proteome profiling for biomarker discovery in broilers with necrotic enteritis

  2025cites this paper
• A Review of Clinical Biomarker Insights: Advances in Diagnosis and Prognosis of Early Alzheimer

  2025cites this paper
• Test-retest reliability of functional near infrared spectroscopy during tasks of inhibitory control and working memory.

  2025cites this paper
• Rationale and Design of the Alpha-1 Biomarkers Consortium Study.

  2025cites this paper
• Hyperreflective Retinal Foci (HRF): Definition and Role of an Invaluable OCT Sign

  2025cites this paper
• Automated extraction of functional biomarkers of verbal and ambulatory ability from multi-institutional clinical notes using large language models

  2025cites this paper
• The Use of Biomarkers to Track and Treat Critical Illness.

  2025cites this paper
• Blood Biomarkers Reflecting Brain Pathology—From Common Grounds to Rare Frontiers

  2025cites this paper
• Role of Biomarkers in Diagnosing Disease, Assessing the Severity and Progression of Disease, and Evaluating the Efficacy of Therapies

  2025cites this paper